Furthermore, decreased SMAD4 expression, a downstream target of TGF-β, is associated with poor prognosis in colon cancer, providing indirect evidence that inactivation of TGF-β signalling leads to the invasive behaviour of colon cancer26. Here, TGFB1 is linked to colonic neoplasm.